Science Explorer Interactive view Map
Research works
38
▼ 45% vs 2013–17
Citations
1.4k
36.5 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
11%
world 28%

Not ranked overall: Robugen (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Robugen (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Synthesis, Medicinal Chemistry, Heterocycles, Herbal Medicine, Drug Discovery, Catalyst, Anticancer Agents and Biological Evaluation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Synthesis6▲ 29×9 topics
  2. Medicinal Chemistry4▲ 29×7 topics
  3. Heterocycles4▲ 59×3 topics
  4. Drug Discovery3▲ 20×5 topics
  5. Herbal Medicine3▲ 35×4 topics
  6. Anticancer Agents3▲ 29×4 topics
  7. Biological Evaluation3▲ 60×3 topics
  8. Catalyst3▲ 71×2 topics
  9. Heterocyclic Compounds3▲ 47×4 topics
  10. Antimicrobial3▲ 27×3 topics
  11. Pharmacology3▲ 21×5 topics
  12. Antioxidant2▲ 9.1×5 topics
  13. Oxidative Stress2▲ 3.0×6 topics
  14. Enzyme Regulation2▲ 103×2 topics
  15. Chemoselective2▲ 36×2 topics
  16. Genomic Stability2▲ 50×2 topics
  17. Tumor Hypoxia2▲ 54×2 topics
  18. Metabolic Disorders2▲ 24×2 topics
  19. Microwave-Assisted Synthesis2▲ 55×2 topics
  20. Oxidation2▲ 21×2 topics
  21. Cancer Therapy2▲ 6.7×4 topics
  22. Nucleotide Metabolism2▲ 117×1 topic
  23. Purine Biosynthesis2▲ 117×1 topic
  24. Antimicrobial Activity2▲ 21×2 topics
  25. Hawthorn2▲ 582×1 topic
  26. Imidazoles2▲ 146×1 topic
  27. Oxazolones2▲ 146×1 topic
  28. Polyphenolic Extracts2▲ 582×1 topic
  29. Therapeutic Targets2▲ 17×2 topics
  30. Anticancer1▲ 20×2 topics
  31. HIF-11▲ 53×1 topic
  32. Warburg Effect1▲ 53×1 topic
  33. Apoptosis1▲ 9.1×5 topics
  34. Cell Death1▲ 17×3 topics
  35. Conformational Analysis1▲ 74×2 topics
  36. DNA Structure1▲ 57×1 topic
  37. Derivatives1▲ 59×1 topic
  38. G-Quadruplexes1▲ 57×1 topic
  39. Quinoxaline1▲ 79×1 topic
  40. Scaffold1▲ 37×1 topic

Which research topics does Robugen (Germany) publish most on?

By volume in 2022–2025: Botanical Studies and Applications, Complementary and Alternative Medicine Studies, Biomedical and Chemical Research and Neurological Disease Mechanisms and Treatments.

  1. 1 Botanical Studies and Applications Plant Science 0 works
  2. 2 Complementary and Alternative Medicine Studies Complementary and alternative medicine 0 works
  3. 3 Biomedical and Chemical Research Surgery 0 works
  4. 4 Neurological Disease Mechanisms and Treatments Neurology 0 works
  5. 5 Cardiovascular Syncope and Autonomic Disorders Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available10.6%not open89.4%

World: 28% of research is openly available.

with international co-authors6.7%domestic only93.3%

World: 19% is written across borders.

How has Robugen (Germany)'s research output changed?

Output in 2018–2022 was 45% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Esslingen am Neckar

All research institutions in Esslingen am Neckar

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.